CCR3 and atopic eczema: Indeed, peTh2 cells from subjects with EGID or atopic dermatitis expressed the Th2-associated chemokine receptor CCR3 and demonstrated enhanced chemotaxis to the CCR3 ligand eotaxin-1, whereas cTh2 cells did not (10).